News

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful ...
Polyrizon Ltd.: Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
My world-leading research on the shocking rise in bowel cancer proves we're missing a vital nutrient that slashes risk of cancer and heart disease, says PROF TIM SPECTO…
Despite decades of astonishing medical advances, heart disease and cancer stubbornly remain two of the biggest killers in the ...